Evolving Early Therapies of “Myocardial Ischemia ...
[Pages:32]STEMI:
Evolving Early Therapies of "Myocardial Ischemia/Reperfusion Injury".
Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC).
- Hospital Cl?nico San Carlos.
Disclosures:
Borja Ibanez has nothing to disclose
Index
1) Reperfusion: a paradigm shift from mortality to HF.
2) Next goal: Infarct size limitation in reperfused STEMI.
3) Ischemia/Reperfusion injury.
4) Therapies to reduce infarct size: Reperfusion + Conditioning. + Cyclosporine-A. + Metoprolol.
Index
1) Reperfusion: a paradigm shift from mortality to HF.
2) Next goal: Infarct size limitation in reperfused STEMI.
3) Ischemia/Reperfusion injury.
4) Therapies to reduce infarct size: Reperfusion + Conditioning. + Cyclosporine-A. + Metoprolol.
STEMI: A paradigm shift
25% Mortality
The great success of
reperfusion therapies
has resulted in a
paradigm shift in STEMI:
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- acute myocardial ischemia definition
- myocardial ischemia definition
- acute myocardial ischemia icd 10
- acute myocardial ischemia treatment
- myocardial ischemia ekg
- myocardial ischemia in women
- myocardial ischemia symptoms
- myocardial ischemia vs myocardial infarction
- myocardial ischemia symptoms in women
- reversible myocardial ischemia icd 10
- myocardial ischemia pronunciation
- myocardial ischemia on ekg